Part 7-2 (Psychotropic Medications) Flashcards

1
Q

Psychotropic Medications

A

Sedative hypnotics
Anti-anxiety drugs
Antipsychotics
Treatment of dementia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Psychosis

A

Much more severe form of mental illness than depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Psychosis cause

A

Increased dopamine activity in specific CNS pathways

Other NTs may be involved (Seratonin, Glutamate, ACh)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Antipsychotics characteristics

A

Block CNS dopamine receptors, especially D2 receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Common antipsychotics

A

Classified as traditional vs newer “atypical” agents

Atypical agents may be preferred d/t fewer/milder effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Traditional antipsychotic examples

A

Chlorpromazine (Thorazine)
Haloperidol (Haldol)
Prochlorperazine (Compazine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Atypical antipsychotic examples

A

Clozapine (Clozaril)
Risperidone (Risperdal)
Olanzapine (Zyprexa)
Quetiapine (Seroquel)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Atypical antipsychotic characteristics

A

Weak blockers of D2 receptors
Strong blockers of serotonin receptors
-Normally better tolerated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Traditional Antipsychotic adverse effects

A
Orthostatic hypotension
Sedation
Anticholinergic effects (Inc. HR, GI problems, dry throat)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Atypical antipsychotic adverse effects

A

Weight gains
Increased blood lipids
Increased gluten sensitivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Primary concern of all antipsychotics

A

Extrapyramidal (motor) side effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Extrapyramidal side effects

A

Tardive Dyskinesia (Oral facial movements)
Pseudoparkinsonism
Akathisia
Other dystonias/dyskinesias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Tardive Dyskinesia

A

25% of patients on long term traditional antipsychotics
Cause: Denervation supersensitivity (post-synaptic neuron makes more receptors)
Can be permanent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Tardive Dyskinesia best treatment

A

Early recognition and change in type or dose of drug.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Tardive Dyskinesia Risk factors

A
Advanced age
Genetic predisposition
Affective mood disorders
Diabetus Mellitus
Hx of alcohol abuse
>6 months continuous use of antipsychotic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Neuroleptic Malignant syndrome

A

Can occur with all antipsychotics

  • Catatonia, rigidity, tremors, fever
  • increased risk if high dose, agitated patient, impaired mental function
  • Can be fatal; need to detect early
17
Q

Dementia

A

Irreversible dementia: Alzheimer disease

Degenerative changes in neuronal structure and function

18
Q

Goals of drug therapy in dementia

A

Improve cognitive and intellectual function

Improve/modify behavior

19
Q

Improving cognitive function

A

Neuronal changes lead to decreased ACh activity in brain

Cholinergic stimulants: increased ACh activity

20
Q

Indirect Cholinergic stimulants: dementia

A

Drug inhibits cholinesterase enzyme
ACh breakdown is inhibited
ACh activity/effects are prolonged

Use in early stages when brain still produces ACh

21
Q

Cholinergic stimulants in Alzheimer

A

Donepezil (Aricept)
Galantamine (Razadyne)
Rivastigmine (Exelon)
Tacrine (Cognex)

22
Q

Memantine (Namenda)

A

Blocks NMDA-glutamate receptors in brain
Normalizes glutamate influence
Slows progression; may be combined with traditional

23
Q

Drugs used to improve or modify behavior

A

Antidepressents
Antianxiety drugs
Antipsychotics

24
Q

Behavior modification in Alzheimer’s

A

Government regulations curb use of antipsychotics
More emphasis on using symptom-specific meds
Consider nonpharmacologic interventions